Category: <span>chemotherapy clinical trial</span>

Mesothelioma Trial for Nintedanib Shows Positive Results

Researchers have reported more promising results from an international, multicenter phase II clinical trial of the drug nintedanib, moving it another step closer to standard-of-care treatment for pleural mesothelioma. Nintedanib is a small-molecule enzyme inhibitor being studied as a way to increase the effectiveness of chemotherapy on mesothelioma and certain types of lung cancer. Researchers…

The post Mesothelioma Trial for Nintedanib Shows Positive Results appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Study Shows Impact of Chemotherapy on Mesothelioma

A U.S.-based study confirms what oncology experts have suggested for years — chemotherapy treatment prolongs life expectancy for malignant mesothelioma patients. Wayne State University School of Medicine researchers linked data from the National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) database with Medicare claims data. The study took into account patient characteristics such as…

The post Study Shows Impact of Chemotherapy on Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.